Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 314 for infectious diseases

Edit search filters
  1. A Study to Evaluate AntiThrombotic Therapy to Lessen Complications of COVID-19 (Enrolling by Invitation Only)

    Rochester, MN

  2. A Study to Evaluate the Efficacy and Safety of Colchicine on Coronavirus SARS-CoV2 Positive Adults

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  3. Vagal Nerve Stimulation for Post-COVID Fatigue

    Rochester, MN

  4. A Study to Evaluate Rivaroxaban to Reduce Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with Acute COVID-19 Infection

    Rochester, MN

  5. A Study to Evaluate a Resiliency Program for Healthcare Professionals During a Pandemic

    Rochester, MN

  6. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

    Scottsdale/Phoenix, AZ

  7. A Study to Evaluate Agents to Treat Moderately or Severely Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2

    Rochester, MN

  8. A Study to Evaluate Fisetin to Alleviate Dysfunction and Inflammation in COVID-19 Subjects

    Rochester, MN

  9. A Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection

    Scottsdale/Phoenix, AZ

  10. A Study to Validate Patient-Reported Outcome Instruments in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer